These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18586075)

  • 1. Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells.
    Zhang XG; Miao J; Dai YQ; Du YZ; Yuan H; Hu FQ
    Int J Pharm; 2008 Sep; 361(1-2):239-44. PubMed ID: 18586075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells.
    Miao J; Du YZ; Yuan H; Zhang XG; Hu FQ
    Colloids Surf B Biointerfaces; 2013 Oct; 110():74-80. PubMed ID: 23711779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.
    Yuan H; Wang LL; Du YZ; You J; Hu FQ; Zeng S
    Colloids Surf B Biointerfaces; 2007 Nov; 60(2):174-9. PubMed ID: 17656075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.
    Wang Y; Zhang H; Hao J; Li B; Li M; Xiuwen W
    Drug Deliv; 2016 May; 23(4):1398-403. PubMed ID: 26079530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment.
    Raikwar S; Vyas S; Sharma R; Mody N; Dubey S; Vyas SP
    AAPS PharmSciTech; 2018 Nov; 19(8):3839-3849. PubMed ID: 30280350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which one performs better for targeted lung cancer combination therapy: pre- or post-bombesin-decorated nanostructured lipid carriers?
    Du J; Li L
    Drug Deliv; 2016 Jun; 23(5):1799-809. PubMed ID: 26455787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
    Hu FQ; Liu LN; Du YZ; Yuan H
    Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.
    Mussi SV; Sawant R; Perche F; Oliveira MC; Azevedo RB; Ferreira LA; Torchilin VP
    Pharm Res; 2014 Aug; 31(8):1882-92. PubMed ID: 24522814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy.
    Li X; Jia X; Niu H
    Int J Nanomedicine; 2018; 13():4107-4119. PubMed ID: 30034236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-tumor and renoprotection study of E-[c(RGDfK)
    Zhang B; Zhang Y; Dang W; Xing B; Yu C; Guo P; Pi J; Deng X; Qi D; Liu Z
    J Nanobiotechnology; 2022 Sep; 20(1):425. PubMed ID: 36153589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
    Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N
    Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody.
    Abdolahpour S; Toliyat T; Omidfar K; Modjtahedi H; Wong AJ; Rasaee MJ; Kashanian S; Paknejad M
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):89-94. PubMed ID: 28296511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
    Yang XY; Li YX; Li M; Zhang L; Feng LX; Zhang N
    Cancer Lett; 2013 Jul; 334(2):338-45. PubMed ID: 22776563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy.
    Liu Q; Li J; Pu G; Zhang F; Liu H; Zhang Y
    Drug Deliv; 2016 May; 23(4):1364-8. PubMed ID: 25874959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
    Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
    Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanostructured lipid carrier co-delivering paclitaxel and doxorubicin restrains the proliferation and promotes apoptosis of glioma stem cells via regulating PI3K/Akt/mTOR signaling.
    Chang L; Zhang Y; Li M; Zhao X; Wang D; Liu J; Zhou F; Zhang J
    Nanotechnology; 2021 Mar; 32(22):. PubMed ID: 33690190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
    Li F; Weng Y; Wang L; He H; Yang J; Tang X
    Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells.
    Wong HL; Rauth AM; Bendayan R; Manias JL; Ramaswamy M; Liu Z; Erhan SZ; Wu XY
    Pharm Res; 2006 Jul; 23(7):1574-85. PubMed ID: 16786442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characteristics of monostearin nanostructured lipid carriers.
    Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
    Int J Pharm; 2006 May; 314(1):83-9. PubMed ID: 16563671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
    Baek JS; Cho CW
    Int J Pharm; 2015 Jan; 478(2):617-24. PubMed ID: 25510604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.